drugset / Trial / NCT07124013
A Study of Olomorasib (LY3537982) in Healthy Japanese Participants
RandomizedCrossoverOpen-labelBasic science
Summary
The purpose of this study is to compare and see how food affects the amount of olomorasib in the blood when olomorasib is taken in two different capsule forms. Participation in the study will last approximately 6 weeks.
Timeline
- Start
- 2025-09-16
- Primary completion
- 2026-01-05
- Completion
- 2026-01-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olomorasib | Small molecule | — | Oral |
Indications
No indication recorded.